1.
Haematologica
; 87(11): 1227-9, 2002 Nov.
Artículo
en Inglés
| MEDLINE
| ID: mdl-12414356
RESUMEN
We treated 30 consecutive untreated patients aged > 70 years with advanced aggressive non-Hodgkin's lymphoma with 6 courses of cyclophosphamide, mitoxantrone, etoposide, bleomycin, vinblastine and dexamethasone (D-VICEMB). The global response was 93%. The 6-year overall survival and progression-free survival were 50%, and disease-free survival was 63%.